U.S. Retail Distributors Stock News

GEO Group (NYSE:GEO) has announced a major CEO transition as founder Dr. George C. Zoley returns to lead the company. The change follows what the company describes as record new business wins and the largest facility expansion in its history. New or expanded contracts are tied to approximately $520 million in annualized revenue and the activation of five major facilities. GEO Group operates correctional, detention, and community reentry facilities, so leadership changes can matter for how...

Why Halliburton’s nuclear waste project is catching investor attention Halliburton (HAL) is stepping into nuclear waste disposal through a multi year deep borehole demonstration program with Deep Isolation and partners. This move could reshape how investors think about its long term opportunity set. See our latest analysis for Halliburton. Alongside the nuclear waste project and recent corporate moves such as a shelf registration and new board committee appointments, Halliburton’s 90 day...

Packaging Corporation of America recently reported past fourth-quarter 2025 earnings and revenue that came in below analyst expectations, prompting questions about profitability and growth opportunities as its operating margin and return on invested capital have both declined in recent years. At the same time, the company remains a favored name among hedge funds and several analysts, who highlight expected price increases, ongoing operational initiatives, and continued demand as reasons for...

Sterling Infrastructure, Inc. ( NASDAQ:STRL ) shareholders have had their patience rewarded with a 34% share price jump...

Scorpio Tankers (STNG) has put up another solid quarter in FY 2025, with Q3 revenue of US$241.4 million and basic EPS of US$1.81, supported by net income of US$84.5 million. The company has seen revenue move from US$380.7 million and EPS of US$4.54 in Q2 2024 to US$203.97 million and EPS of US$1.48 in Q4 2024, then to US$214.0 million and EPS of US$1.26 in Q1 2025 and US$230.2 million and EPS of US$1.59 in Q2 2025, giving investors a clear view of how the top line and EPS have tracked into...

If you are wondering whether Qiagen's current share price still offers value or if the opportunity has already passed you by, you are in the right place. Qiagen's share price last closed at US$50.85, with a 7.7% return over the past 30 days and a 27.4% return over the last year, although the past week shows a modest 0.7% decline. Recent news around Qiagen has focused on its position in the pharmaceuticals and biotech space, including ongoing interest in its role as a supplier of molecular...

Mibanco, the microfinance arm of Credicorp (NYSE:BAP), is partnering with Temenos to modernize its core banking platform using software as a service. The collaboration focuses on faster product launches, improved customer experience, and broader financial inclusion for small businesses in Peru. For Credicorp, which has a strong presence in microfinance through Mibanco, this tech upgrade relates directly to how banking services are delivered to small and midsize enterprises in Peru. The move...

In late January, Lennox International reported fourth-quarter results that missed Wall Street forecasts, with adjusted EPS of US$4.45 versus expectations of US$4.76 and revenue of US$1.20 billion compared with a US$1.30 billion consensus, as channel destocking and soft residential construction weighed on performance. Beyond the headline miss, the company’s upcoming March 4 Investor Day in the Dallas–Fort Worth area will give investors a closer look at how management plans to address these...

In recent weeks, Deere & Company outlined plans to report its first-quarter fiscal 2026 results on February 19, while highlighting ongoing margin pressures from tariffs, soft large-ag equipment demand, and continued investment in precision agriculture, automation, and autonomous systems. At the same time, Deere expanded its 2026 Startup Collaborator Program to five new partners in monitoring, sensing, AI, robotics, and data analytics, underlining how external innovation is being woven into...

Live Nation Entertainment (LYV) is back in focus after reports that the company is in talks with the U.S. Department of Justice to settle monopoly accusations without going to trial, a development closely watched by investors. See our latest analysis for Live Nation Entertainment. The stock has been active, with a 2.49% 1 day share price return and a 12.00% 7 day share price return, while the 1 year total shareholder return sits at 1.50% and the 3 year total shareholder return is 98.02%. This...

If you are wondering whether Arlo Technologies at around US$11.23 is offering good value today, you are not alone. This article is built to help you frame that question clearly. The stock has had a mixed run, with a 6.6% decline over the last 7 days, an 18.7% decline over the last 30 days, a 15.1% decline year to date and a 2.2% decline over 1 year, set against a very large gain over 3 years and a 54.3% gain over 5 years. Recent attention on Arlo has been shaped by ongoing discussions around...

If you are wondering whether Omnicell's current share price really reflects its potential, this article will walk through how the stock stacks up on value. The shares most recently closed at US$36.18, after returns of a 7.4% decline over 7 days, 29.6% decline over 30 days, 19.8% decline year to date, 10.1% decline over 1 year, 33.5% decline over 3 years, and 72.1% decline over 5 years. Recent news coverage around Omnicell has focused on the company as part of broader discussions about...

Earlier this week, The Kroger Co. appointed veteran retail executive Greg Foran, former Walmart U.S. chief and Air New Zealand CEO, as its new Chief Executive Officer and added him to the board, with former interim CEO Ron Sargent remaining as Chairman to support the transition. Foran’s track record leading complex turnarounds and large-scale digital upgrades in both retail and aviation gives Kroger fresh leadership experience in culture-building, e-commerce and operational rigor at a time...

Copart (CPRT) is back in focus after scheduling its second quarter fiscal 2026 earnings release for February 19 and recently securing a new US$1.25b unsecured revolving credit facility. See our latest analysis for Copart. The upcoming earnings release and fresh US$1.25b credit facility come after a softer period for the shares, with a 1 year total shareholder return decline of 38.63% and a 5 year total shareholder return of 23.67%. This suggests that shorter term momentum has faded while...

Molina Healthcare recently reported a fourth-quarter 2025 loss and sharply weaker 2026 profit guidance, citing elevated medical costs, retroactive Medicaid adjustments, and plans to exit its underperforming Medicare Advantage Part D product in 2027. Alongside a US$93 million non-cash impairment and a covenant amendment that temporarily relaxes its minimum interest coverage ratio, these developments have raised fresh questions about the resilience of Molina’s business model under sustained...

In early February 2026, GitLab Inc. hosted its GitLab Transcend virtual event and related calls to showcase how its Intelligent Orchestration and agentic AI capabilities can automate software delivery while preserving security, compliance, and governance. The company also launched initiatives such as an AI agent hackathon and a forthcoming assessment program, underscoring a broader shift toward AI-led workflows and away from traditional seat-based models that many analysts now see as...

NRG Energy (NRG) is back on watch for investors after recent share price moves, with the stock closing at $161.80 as the company continues operating across power generation, retail energy and home services. See our latest analysis for NRG Energy. The latest move to $161.80 extends a 7 day share price return of 12.02% and a 30 day share price return of 7.44%. However, year to date the share price return is slightly negative, while the 1 year total shareholder return of 54.17% and very large 3...

Fluor (NYSE:FLR) has been selected as the lead EPC contractor for Centrus Energy's expansion of U.S. uranium enrichment capacity. The multi year project is aimed at supporting commercial and national security needs for enriched uranium in the United States. The contract reinforces Fluor's role in large scale nuclear and energy infrastructure at a time of growing focus on domestic fuel capabilities. For investors tracking NYSE:FLR, this new EPC role arrives with the stock at $45.67 and multi...

AGNC Investment (AGNC) has reaffirmed its monthly dividend, declaring a US$0.12 per share cash payout for February 2026. This decision puts income reliability and dividend sustainability back in the spotlight for investors. See our latest analysis for AGNC Investment. AGNC’s share price sits at US$11.38 after a modest 90 day share price return of 12.12%, while its 1 year total shareholder return of 27.58% highlights how the dividend has shaped overall results over time. If this dividend news...

Confluent (CFLT) just wrapped up FY 2025 with Q4 revenue of US$314.8 million and a basic EPS loss of US$0.23, while trailing twelve month revenue sat at about US$1.17 billion against a full year basic EPS loss of US$0.86. Over recent quarters, the company has seen revenue move from US$261.2 million in Q4 2024 to US$314.8 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.19 and US$0.27. The latest print keeps the spotlight firmly on how quickly revenue growth can offset...

If you are wondering whether PennyMac Mortgage Investment Trust is offering good value at its recent share price, you are not alone. This article is designed to help you make sense of that question. The stock most recently closed at US$12.49, with returns of 2.0% over the past week, a 5.2% decline over the past month, a 1.3% decline year to date, and a 3.4% return over the last year, alongside cumulative returns of 26.2% over three years and 22.1% over five years. Recent coverage has focused...

Sarepta Therapeutics (NasdaqGS:SRPT) received Medsafe approval in New Zealand for its first-in-human clinical trial of SRP-1005. SRP-1005 is an investigational siRNA therapeutic targeting Huntington's Disease, a severe neurodegenerative condition. The authorization allows Sarepta to begin a Phase 1 study, marking its clinical entry into Huntington's Disease research. Sarepta Therapeutics is best known for its Duchenne muscular dystrophy franchise, and SRP-1005 broadens its rare disease...

Core Natural Resources (CNR) has posted a mixed set of FY 2025 numbers, with Q3 revenue at about US$1.0 billion and basic EPS of US$0.61 alongside a trailing twelve month loss of US$43.4 million on basic EPS of US$0.94. The company has seen quarterly revenue move from US$553.4 million in Q3 2024 to more than US$1.0 billion in Q3 2025, while basic EPS has swung between a profit of US$3.23 and a loss of US$1.38 over that stretch. This highlights how volatile margins have been. For investors,...

If you are wondering whether Easterly Government Properties is fairly priced or offering value right now, this article will walk you through what the numbers actually say. The stock last closed at US$23.79, with a 30 day return of 6.3% and an 11.6% return year to date, set against a 3.1% decline over the past year and a 23.7% and 37.1% decline over the past 3 and 5 years respectively. Recent coverage of Easterly Government Properties has focused on its position as a real estate investment...